336 related articles for article (PubMed ID: 17308944)
1. Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension.
Assadi F
Pediatr Cardiol; 2007; 28(1):27-33. PubMed ID: 17308944
[TBL] [Abstract][Full Text] [Related]
2. Regression of left-ventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapy.
Seeman T; Gilík J; Vondrák K; Simková E; Flögelová H; Hladíková M; Janda J
Am J Hypertens; 2007 Sep; 20(9):990-6. PubMed ID: 17765141
[TBL] [Abstract][Full Text] [Related]
3. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
[TBL] [Abstract][Full Text] [Related]
4. Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment.
Rodilla E; Pascual JM; Costa JA; Martin J; Gonzalez C; Redon J
J Hypertens; 2013 Aug; 31(8):1683-91. PubMed ID: 23835910
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein and incident left ventricular hypertrophy in essential hypertension.
Assadi F
Pediatr Cardiol; 2007; 28(4):280-5. PubMed ID: 17563829
[TBL] [Abstract][Full Text] [Related]
6. Relation of left ventricular hypertrophy to microalbuminuria and C-reactive protein in children and adolescents with essential hypertension.
Assadi F
Pediatr Cardiol; 2008 May; 29(3):580-4. PubMed ID: 18046596
[TBL] [Abstract][Full Text] [Related]
7. Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients.
Cuspidi C; Meani S; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
J Hum Hypertens; 2005 Jun; 19(6):471-7. PubMed ID: 15744331
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
9. Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin system.
du Cailar G; Fesler P; Ribstein J; Mimran A
Hypertension; 2010 Nov; 56(5):865-70. PubMed ID: 20921428
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure levels, left ventricular mass and function are correlated with left atrial volume in mild to moderate hypertensive patients.
Milan A; Caserta MA; Dematteis A; Naso D; Pertusio A; Magnino C; Puglisi E; Rabbia F; Pandian NG; Mulatero P; Veglio F
J Hum Hypertens; 2009 Nov; 23(11):743-50. PubMed ID: 19262581
[TBL] [Abstract][Full Text] [Related]
11. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
[TBL] [Abstract][Full Text] [Related]
12. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
[TBL] [Abstract][Full Text] [Related]
13. Optimal control of blood pressure can reverse left ventricular hypertrophy in uremic hypertensive hemodialysis patients.
Wu SG; Lin SL; Wu CM; Jeng FR; Su CZ
Kaohsiung J Med Sci; 1999 Feb; 15(2):62-8. PubMed ID: 10089714
[TBL] [Abstract][Full Text] [Related]
14. Clinical correlates of left ventricular mass in elderly hypertensives.
James MA; Fotherby MD; Potter JF
J Hum Hypertens; 1994 Jun; 8(6):409-15. PubMed ID: 8089825
[TBL] [Abstract][Full Text] [Related]
15. Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients.
Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Maisaidi M; Zanchetti A
Blood Press; 2006; 15(2):107-15. PubMed ID: 16754274
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular hypertrophy in nondiabetic predialysis CKD.
Paoletti E; Bellino D; Cassottana P; Rolla D; Cannella G
Am J Kidney Dis; 2005 Aug; 46(2):320-7. PubMed ID: 16112052
[TBL] [Abstract][Full Text] [Related]
17. Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension.
Thürmann PA; Kenedi P; Schmidt A; Harder S; Rietbrock N
Circulation; 1998 Nov; 98(19):2037-42. PubMed ID: 9808602
[TBL] [Abstract][Full Text] [Related]
18. Microalbuminuria, left ventricular mass and ambulatory blood pressure in essential hypertension.
Redon J; Baldo E; Lurbe E; Bertolin V; Lozano JV; Miralles A; Pascual JM
Kidney Int Suppl; 1996 Jun; 55():S81-4. PubMed ID: 8743518
[TBL] [Abstract][Full Text] [Related]
19. Time course of complete normalization of left ventricular hypertrophy during long-term antihypertensive therapy with angiotensin converting enzyme inhibitors.
Franz IW; Tönnesmann U; Müller JF
Am J Hypertens; 1998 Jun; 11(6 Pt 1):631-9. PubMed ID: 9657621
[TBL] [Abstract][Full Text] [Related]
20. The importance of left ventricular hypertrophy in human hypertension.
Kahan T
J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
